• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 026 Publication Date: 03/18/2011 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 1-84: ISO 5366-3:2001, Anaesthetic and Respiratory Equipment -- Tracheostomy Tubes -- Part 3: Pediatric Tracheostomy Tubes TECHNICAL CORRIGENDUM 1. (Anesthesias)

Date of Standard: 2003. 
Address of Standards Organization:
  International Organization for Standardization (ISO)*
  1, Rue de Varembe
  Case Postale 56
  CH 1211 Geneva 20, 0
  SWITZERLAND
CDRH Offices and Divisions Associated with Recognized Standards:
(1)OFFICE OF COMPLIANCE (OC)
(2)OFFICE OF SURVEILLANCE AND BIOMETRICS (OSB)
DIVISION OF POSTMARKET SURVEILLANCE (DPS)
(3)OFFICE OF DEVICE EVALUATION (ODE)
Devices Affected:
Tracheostomy Tubes Made of Elastomeric and/or Rubber Materials and Connectors
Processes Affected:
All Pediatric Tracheostomy Tubes
Type of Standard:
 Vertical, International
Extent of Recognition:
Complete 2003 Technical Corrigendum 1

Additional Note: for conformance with ISO 5366-3:2001; refer to standard recognition number 1-36 which refers its extent of recognition as follows:

Clause 6.1. Information related to the resistance to cleaning, disinfection, and sterilization agents should be provided, including a description of test methods, acceptance criteria, and results. For those devices that use ethylene oxide as a sterilant, the residue levels of ethylene oxide, ethylene chlorohydrin, and ethylene glycol shall not exceed 250 ppm, 250 ppm, and 5000 ppm, respectively.

Clause 4.3. is recognized with clarification. Because the device is considered to have permanent-duration contact with tissue and mucosal membrane, the device is considered external communicating, and reports of cytotoxicity, sensitization, genotoxicity, and implantation testing should be provided as indicated in ISO 10993-1. All biocompatibility test should be performed after the device has been sterilized initially (for products provided sterile) or after recommended sterilization procedure.

Clause 4.6. is not recognized. ASTM F 1242-96, Section 5.1 applies.

Clause 7.1 is not recognized. 21 CFR 801.15(c)(1) states that all words, statements, and other information required by the Act to appear on the label or labeling shall appear in the English language. English labeling allows immediate and positive verification for the proper use of medical equipment. As outlined in 21 CFR 807.87(e), proposed labels and labeling shall be sufficient to describe the directions for use of the device, and Section 502(f) of the Act requires adequate directions for use. All device labeling should contain English text adjacent to any icons/symbols used if space permits. If space does not permit, the icon/symbols should be replaced with English text only.

Clause 7.2.1.1b is recognized in part. Markings on trachel tubes which indicates inner or outer diameter should be accompanied by text or letters identifying the numbers as diameters.

ASTM F 1242-96, Section 5.1 and A1.3 (cuff symmetry test) and ASTM F 1242-96, Section 5.3 and A1.7 (leak test) also apply.

Annex D.1.1 Information related to the tube rigidity characteristics shall be provided, including a description of the test methods and results.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§868.5800 Tube Tracheostomy And Tube Cuff Class 2 JOH
§868.5800 Tube, Tracheostomy (W/Wo Connector) Class 2 BTO
 
Relevant Guidance:
Reviewer Guidance for labeling reusable medical devices for reprocessing in health care facilities, April 1996
FDA Technical Contact:
  Tam Cillie
  FDA/CDRH/ODE
  10903 New Hampshire Avenue Building 66, Room 2536
  Silver Spring MD 20993
  301/796-6269
  Email: tam.cillie@fda.hhs.gov
* In the United States, copies of this standard can be obtained from:
  American National Standards Institute (ANSI)*
  25 West 43rd Street
  4th Floor
  New York, NY 10036
-
-